{"entity":{"id":"paper-aruhuri-hpv-prevalence-vanuatu-cancerprevres-2012","kind":"paper","name":"Prevalence of cervical human papillomavirus (HPV) infection in Vanuatu","aka":[],"tldr":"A population-based survey of 987 women in Vanuatu found high-risk HPV types in 21.7%, and cervical abnormalities in 13.6% of the 840 with adequate cytology, including invasive cancer in 0.8%.","summary":"A population-based survey in Vanuatu of women aged 18 to 64, carried out to describe HPV prevalence and the distribution of HPV types in the Pacific islands. HPV was tested by a PCR assay, and by hybrid capture 2 performed in Vanuatu.","asOf":"2026-11-16","links":[{"label":"DOI","url":"https://doi.org/10.1158/1940-6207.capr-11-0515"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/22427345/"}],"tags":[],"related":[],"cancers":["cervical"],"sections":[],"technologies":["hpv-testing"],"targets":[],"drugs":[],"companies":[],"institutions":["vanuatu-ministry-of-health"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"journal":"Cancer Prevention Research","year":2012,"doi":"10.1158/1940-6207.capr-11-0515","pmid":"22427345","authors":"Aruhuri B, Tarivonda L, Tenet V, et al.","paperType":"observational","findings":["The prevalence of 44 HPV types was 28.4% (age-standardised 25.0%, 95% CI 21.9 to 28.0); of high-risk types, 21.7% (age-standardised 19.2%, 95% CI 16.4 to 22.0).","Among 840 women with adequate cytology, 13.6% had cervical abnormalities, including 3.6% with high-grade squamous intraepithelial lesions and 0.8% with invasive cervical carcinoma.","HPV prevalence declined from 46.1% in women aged 21 or under to 15.3% in those aged 45 or over.","Nearly half of screening-positive women could not be re-evaluated, mainly because they were difficult to trace."],"whatItMeans":"It measured how common HPV and cervical abnormalities were among women in Vanuatu, and it carries its authors' case for a rapid HPV test with treatment at the same visit.","caveats":["Fieldwork predates 2012, so it does not measure present prevalence or the effect of HPV vaccination.","A survey of HPV and cytology, not of cancer incidence."],"participants":987},"route":"/key-papers/paper-aruhuri-hpv-prevalence-vanuatu-cancerprevres-2012/","neighbours":{"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"}],"technology":[{"id":"hpv-testing","kind":"technology","name":"HPV DNA testing and self-sampling","route":"/technologies/hpv-testing/"}],"institution":[{"id":"vanuatu-ministry-of-health","kind":"institution","name":"Ministry of Health, Vanuatu","route":"/institutions/vanuatu-ministry-of-health/"}]}}